References
- Saulsbury FT. Henoch-Schonlein purpura. Curr Opin Rheumatol 2001;13:35-40. https://doi.org/10.1097/00002281-200101000-00006
- Rostoker G. Schonlein-Henoch purpura in children and adults: diagnosis, pathophysiology and management. Bio Drugs 2001;15:99-138.
- Huber AM, King J, McLaine P, Klassen T, Pothos M. A randomized, placebo-controlled trial of prednisone in early Henoch Schonlein purpura [ISRCTN85109383]. BMC Med 2004;2:7. https://doi.org/10.1186/1741-7015-2-7
- Ronkainen J, Koskimies O, Ala-Houhala M, Antikainen M, Merenmies J, Rajantie J, et al. Early prednisone therapy in henoch-schonlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr 2006;149:241-7. https://doi.org/10.1016/j.jpeds.2006.03.024
- Weiss PF, Feinstein JA, Luan X, Burnham JM, Feudtner C. Effects of corticosteroid on Henoch-Schonlein purpura: a systematic review. Pediatrics 2007;120:1079-87. https://doi.org/10.1542/peds.2007-0667
- Calvo-Rio V, Loricera J, Mata C, Martin L, Ortiz-Sanjuan F, Alvarez L, et al. Henoch-Schonlein purpura in northern Spain: clinical spectrum of the disease in 417 patients from a single center. Medicine (Baltimore) 2014;93:106-13. https://doi.org/10.1097/MD.0000000000000019
- Lu S, Liu D, Xiao J, Yuan W, Wang X, Zhang X, et al. Comparison between adults and children with Henoch-Schonlein purpura nephritis. Pediatr Nephrol 2015;30:791-6. https://doi.org/10.1007/s00467-014-3016-z
- Shin JI, Park JM, Shin YH, Hwang DH, Kim JH, Lee JS. Predictive factors for nephritis, relapse, and significant proteinuria in childhood Henoch-Schonlein purpura. Scand J Rheumatol 2006;35:56-60. https://doi.org/10.1080/03009740510026841
- Hong JH, Na HJ, Namgung MG, Choe SO, Han BG, Jeong SH, et al. Different clinical courses of Henoch-Schonlein purpura in children, adolescents and adults. Korean J Pediatr 2005;48:1244-51.
- Cohen N, Mimouni FB, Friedel N, Amarilyo G. Predictors of hospital length of stay in pediatric Henoch-Schonlein purpura. Rheumatol Int 2015;35:1561-4. https://doi.org/10.1007/s00296-015-3257-6
- Oh JM, Park JH. Clinical features of Henoch-Schonlein purpura gastroenteropathy without purpura before diagnosis. Korean J Pediatr Gastroenterol Nutr 2004;7:54-60.
- Yang HR, Choi WJ, Ko JS, Seo JK. Intravenous immunoglobulin for severe gastrointestinal manifestation of Henoch-Schonlein purpura refractory to corticosteroid therapy. Korean J Pediatr 2006;49:784-9. https://doi.org/10.3345/kjp.2006.49.7.784
- Jauhola O, Ronkainen J, Autio-Harmainen H, Koskimies O, Ala-Houhala M, Arikoski P, et al. Cyclosporine A vs. methylprednisolone for Henoch-Schonlein nephritis: a randomized trial. Pediatr Nephrol 2011;26:2159-66. https://doi.org/10.1007/s00467-011-1919-5
- Kawasaki Y, Suzuki J, Murai M, Takahashi A, Isome M, Nozawa R, et al. Plasmapheresis therapy for rapidly progressive Henoch-Schonlein nephritis. Pediatr Nephrol 2004;19:920-3.
- Park JM, Won SC, Shin JI, Yim H, Pai KS. Cyclosporin A therapy for Henoch-Schonlein nephritis with nephrotic-range proteinuria. Pediatr Nephrol 2011;26:411-7. https://doi.org/10.1007/s00467-010-1723-7
- Cherqaoui B, Chausset A, Stephan JL, Merlin E. Intravenous immunoglobulins for severe gastrointestinal involvement in pediatric Henoch-Schonlein purpura: a French retrospective study. Arch Pediatr 2016;23:584-90. https://doi.org/10.1016/j.arcped.2016.03.018
- Basaran O, Cakar N, Uncu N, Celikel BA, Kara A, Cayci FS, et al. Plasma exchange therapy for severe gastrointestinal involvement of Henoch Schonlein purpura in children. Clin Exp Rheumatol 2015;33:S-176-80.
- Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP, et al. The american college of rheumatology 1990 criteria for the classification of Henoch-Schonlein purpura. Arthritis Rheum 1990;33:1114-21.
- Saulsbury FT. Henoch-Schonlein purpura in children. Report of 100 patients and review of the literature. Medicine (Baltimore) 1999;78:395-409. https://doi.org/10.1097/00005792-199911000-00005
- Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, Holtta T, et al. Clinical course of extrarenal symptoms in Henoch-Schonlein purpura: a 6-month prospective study. Arch Dis Child 2010;95:871-6. https://doi.org/10.1136/adc.2009.167874
- Weiss PF, Klink AJ, Localio R, Hall M, Hexem K, Burnham JM, et al. Corticosteroids may improve clinical outcomes during hospitalization for Henoch-Schonlein purpura. Pediatrics 2010;126:674-81. https://doi.org/10.1542/peds.2009-3348
- Masarweh K, Horovitz Y, Avital A, Spiegel R. Establishing hospital admission criteria of pediatric Henoch-Schonlein purpura. Rheumatol Int 2014;34:1497-503. https://doi.org/10.1007/s00296-014-2971-9
- Choi SM, Lee KY. Clinico-epidemiologic study of Henoch-Schonlein purpura in children, 1987 through 2003. Korean J Pediatr 2005;48:174-77.
- Zhao YL, Liu ZJ, Bai XM, Wang YC, Li GH, Yan XY. Obesity increases the risk of renal involvement in children with Henoch-Schonlein purpura. Eur J Pediatr 2015;174:1357-63. https://doi.org/10.1007/s00431-015-2547-z
- Anil M, Aksu N, Kara OD, Bal A, Anil AB, Yavascan O, et al. Henoch-Schonlein purpura in children from western Turkey: a retrospective analysis of 430 cases. Turk J Pediatr 2009;51:429-36.
- Kang Y, Park JS, Ha YJ, Kang MI, Park HJ, Lee SW, et al. Differences in clinical manifestations and outcomes between adult and child patients with Henoch-Schonlein purpura. J Korean Med Sci 2014;29:198-203. https://doi.org/10.3346/jkms.2014.29.2.198
- Hong J, Yang HR. Laboratory markers indicating gastrointestinal involvement of Henoch-Schonlein purpura in children. Pediatr Gastroenterol Hepatol Nutr 2015;18:39-47. https://doi.org/10.5223/pghn.2015.18.1.39
- Nagamori T, Oka H, Koyano S, Takahashi H, Oki J, Sato Y, et al. Construction of a scoring system for predicting the risk of severe gastrointestinal involvement in Henoch-Schonlein purpura. Springerplus 2014;3:171. https://doi.org/10.1186/2193-1801-3-171
- Sano H, Izumida M, Shimizu H, Ogawa Y. Risk factors of renal involvement and significant proteinuria in Henoch-Schonlein purpura. Eur J Pediatr 2002;161: 196-201. https://doi.org/10.1007/s00431-002-0922-z
- Choi HJ, Cho HY, Kim EJ, Lee BS, Kang HG, Ha IS, et al. Prognostic factors in children with Henoch-Schonlein purpura nephritis. J Korean Soc Pediatr Nephrol 2005;9:183-92.
- Tabel Y, Inanc FC, Dogan DG, Elmas AT. Clinical features of children with Henoch-Schonlein purpura: risk factors associated with renal involvement. Iran J Kidney Dis 2012;6:269-74.
- Wang X, Zhu Y, Gao L, Wei S, Zhen Y, Ma Q. Henoch-Schonlein purpura with joint involvement: analysis of 71 cases. Pediatr Rheumatol Online J 2016;14:20. https://doi.org/10.1186/s12969-016-0080-x
- Kim SW, Yoon JW, Jeong SJ. Comparison of the clinical manifestations and prognosis of Henoch-Schonlein purpura in children with and without abdominal pain. Korean J Pediatr Gastroenterol Nutr 2011;14:359-67. https://doi.org/10.5223/kjpgn.2011.14.4.359
- Nam EJ, Kim GW, Kang JW, Im CH, Jeon SW, Cho CM, et al. Gastrointestinal bleeding in adult patients with Henoch-Schonlein purpura. Endoscopy 2014;46:981-6. https://doi.org/10.1055/s-0034-1377757
- Esaki M, Matsumoto T, Nakamura S, Kawasaki M, Iwai K, Hirakawa K, et al. GI involvement in Henoch-Schonlein purpura. Gastrointest Endosc 2002;56:920-3. https://doi.org/10.1016/S0016-5107(02)70376-3
- Park SH, Nam YN, Park SH, Sim SY, Eun BW, Choi DY, et al. Clinical characteristics of childhood Henoch-Schonlein purpura with duodenal involvement by upper gastrointestinal endoscopy. Korean J Pediatr Gastroenterol Nutr 2009;12:156-62.
- Dudley J, Smith G, Llewelyn-Edwards A, Bayliss K, Pike K, Tizard J. Randomised, double-blind, placebo- controlled trial to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Schonlein purpura (HSP). Arch Dis Child 2013;98:756-63. https://doi.org/10.1136/archdischild-2013-303642
- Shin JI, Lee SJ, Lee JS, Kim KH. Intravenous dexamethasone followed by oral prednisolone versus oral prednisolone in the treatment of childhood Henoch-Schonlein purpura. Rheumatol Int 2011;31:1429-32. https://doi.org/10.1007/s00296-010-1507-1
- Deng F, Lu L, Zhang Q, Hu B, Wang SJ, Huang N. Henoch-Schonlein purpura in childhood: treatment and prognosis. Analysis of 425 cases over a 5-year period. Clin Rheumatol 2010;29:369-74. https://doi.org/10.1007/s10067-009-1329-2
- Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, Holtta T, et al. Outcome of Henoch-Schonlein purpura 8 years after treatment with a placebo or prednisone at disease onset. Pediatr Nephrol 2012;27:933-9. https://doi.org/10.1007/s00467-012-2106-z
Cited by
- Late Relapse of Henoch-Schönlein Purpura in an Adolescent Presenting as Severe Gastroduodenitis vol.6, pp.None, 2018, https://doi.org/10.3389/fped.2018.00355
- What We Know about Henoch-Schönlein Purpura in Children up to Date? vol.33, pp.25, 2016, https://doi.org/10.3346/jkms.2018.33.e199
- Incidence and risk factors for recurrent Henoch-Schönlein purpura in children from a 16-year nationwide database vol.16, pp.1, 2018, https://doi.org/10.1186/s12969-018-0247-8
- Analysis of seasonal tendencies in pediatric Henoch–Schönlein purpura and comparison with outbreak of infectious diseases vol.97, pp.36, 2018, https://doi.org/10.1097/md.0000000000012217
- Recurrent Henoch Schönlein purpura without renal involvement successfully treated with methotrexate vol.64, pp.2, 2019, https://doi.org/10.1177/0036933018809816
- Changes of IL-17 and related cytokines in peripheral blood and intestinal mucosa of children with abdominal Henoch-Schonlein purpura vol.27, pp.11, 2016, https://doi.org/10.11569/wcjd.v27.i11.694
- Changes in clinical features in Henoch-Schönlein purpura during three decades: an observational study at a single hospital in Korea vol.38, pp.10, 2016, https://doi.org/10.1007/s10067-019-04628-9
- Changes of inflammatory mediators and oxidative stress indicators in children with Henoch-Schönlein purpura and clinical effects of hemoperfusion in the treatment of severe Henoch-Schönlein vol.19, pp.1, 2019, https://doi.org/10.1186/s12887-019-1802-2
- Clinical and Demographic Features of 195 Pediatric Patients with Henoch-Schönlein Purpura, 12-Year Single Center Experience in Shiraz vol.8, pp.4, 2016, https://doi.org/10.5812/pedinfect.99364
- Efficacy and safety of Xijiao Dihuang decoction in treating Henoch-Schönlein purpura : Study protocol for systematic review vol.100, pp.51, 2016, https://doi.org/10.1097/md.0000000000028291
- Clinical spectrum and outcome of immunoglobulin A vasculitis in children: A 10‐year clinical study vol.75, pp.4, 2016, https://doi.org/10.1111/ijcp.13930
- Epidemiological and clinical aspects of immunoglobulin A vasculitis in childhood: a retrospective cohort study vol.47, pp.1, 2021, https://doi.org/10.1186/s13052-021-01182-6